Overview
Jeffrey L. Cummings is a alzheimer’s drug development specialist with an H-index of 196 at University of Nevada, Las Vegas (Faculty). Has been published in The Lancet Neurology, The Lancet, Nature Genetics. Based in United States.
Biography
Social-emotional agnosia, also known as emotional agnosia or expressive agnosia, is the inability to perceive facial expressions, body language, and voice intonation. A person with this disorder is unable to non-verbally perceive others' emotions in social situations, limiting normal social interactions. The condition causes a functional blindness to subtle non-verbal social-emotional cues in voice, gesture, and facial expression. People with this form of agnosia have difficulty in determining and identifying the motivational and emotional significance of external social events, and may appear emotionless or agnostic. Symptoms of this agnosia can vary depending on the area of the brain affected. Social-emotional agnosia often occurs in individuals with schizophrenia and autism. It is difficult to distinguish from, and has been found to co-occur with, alexithymia.
Affiliations & Institutions
Research Impact
5 Publications
0 Total Citations
Published In
J Am Geriatr SocMol PsychiatryLancet NeurolNat Rev Dis PrimersAlzheimers Res Ther
Key Publications
The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.
The Amyloid-β Pathway in Alzheimer's Disease.
Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group.
Alzheimer's disease.
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody.
Areas of Expertise
Medical Specialties
Media Archive